Syngene International Faces Financial Challenges Amid Strong Liquidity and Institutional Confidence

Nov 12 2025 08:05 AM IST
share
Share Via
Syngene International has recently experienced a change in its evaluation, reflecting shifts in financial metrics and market positioning. The company reported strong operating cash flow but faced challenges with a decline in profit after tax. Key performance indicators show pressures on profitability, despite a favorable debt-to-equity ratio and significant institutional holding.
Syngene International, a small-cap player in the healthcare services sector, has recently undergone an adjustment in its evaluation. This revision reflects notable shifts in financial metrics and market positioning. The company reported its highest operating cash flow at Rs 1,167.60 crore, indicating a strong liquidity position. However, the financial landscape has shown some challenges, particularly with a significant decline in profit after tax for the quarter ending September 2025, which stood at Rs 67.10 crore, marking a notable drop compared to previous averages.

Key performance indicators reveal that the operating profit to interest ratio is at its lowest, recorded at 15.11 times, while the profit before depreciation, interest, and tax (PBDIT) also reached a low of Rs 199.50 crore. Additionally, the operating profit to net sales ratio is at 21.91%, reflecting pressures on profitability.

Despite these challenges, Syngene International maintains a low debt-to-equity ratio, which is favorable, and has a high institutional holding at 40.93%. This suggests a level of confidence from institutional investors, who often have the resources to conduct thorough analyses of company fundamentals.

For more insights on Syngene International's financial trends and performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News